Diagnostics and Newborn Screening: Unlocking the Niemann-Pick Disease Market
In rare diseases, diagnosis is the gateway to treatment — and in Niemann-Pick disease, that gateway has historically been narrow. Patients often endure long diagnostic odysseys, visiting multiple specialists before receiving a definitive answer. This delay not only harms patients but also suppresses the size of the addressable market. The Niemann-Pick disease market is therefore being...
0 Comments 0 Shares 90 Views 0 Reviews